Simply put: COVID-19 vaccine exploration

What we know so far about COVID-19 vaccine: A comprehensive guide by academic experts

With so much at stake, it’s not surprising that COVID-19 vaccines have become a public and political obsession. The good news is that …

Simply put: Let’s plant a COVID-19 vaccine

Simply Put: The vaccine

Coronavirus vaccine: Why it’s important to know what’s in the placebo

Adding an actual vaccine to the placebo control helps the trial remain blinded and prevents bias arising from differing expectations

कोरोना वैक्सीन अपडेट: 13 फीसदी धनी देशों ने खरीदी आधी से ज्यादा वैक्सीन खुराक: ऑक्सफैम

ऑक्सफैम ने अपनी एक रिपोर्ट में कहा है कि दुनिया की 61 फीसदी आबादी तक 2022 के अंत तक भी वैक्सीन नहीं पहुंच पाएगी

Coping with COVID-19 need not derail progress against rabies

Rabies control efforts must innovate and adapt to protect the life-saving gains of the last century

वैक्सीन पर पूरी तरह भरोसा नहीं करते लोग: लांसेट

वैक्सीन पर लोग कितना भरोसा करते हैं, इस बारे में लांसेट ने 149 देशों के 284,381 व्यक्तियों लोगों के बीच एक सर्वेक्षण किया

येल यूनिवर्सिटी ने फाइब्रोसिस की खोजी नयी दवा, कोविड-19 के इलाज में हो सकती है सहायक

येल यूनिवर्सिटी के शोधकर्ताओं द्वारा खोजी गयी 'सोबेट्रियम' नामक यह दवा कोविड-19 के मरीजों में होने वाले एक्यूट रेस्पिरेटरी डिस्ट्रेस सिंड्रोम की रोकथाम और उपचार में कारगर ...

कोरोना वैक्सीन अपडेट: नोटिस के बाद सीरम इंस्टिट्यूट ने ट्रायल रोका

कोरोना वैक्सीन ट्रायल में शामिल एक कार्यकर्ता के बीमार पड़ने पर एस्ट्राजेनेका ने फिलहाल काम रोक दिया है

Simply Put: Russian COVID-19 vaccine

COVID-19: Do antibodies hold the key

Watch what new research in Israel, the Netherlands have come up with 

Coronavirus update: Total cases in India cross 6 mln-mark

At least 1,000 more deaths recorded in last 24 hours in India; total death tally more than 95,000  

A promise of equitable access to all

WHO, pharma giants and governments have come together to provide access to all on COVID-19 therapies. But will WIPO allow this to happen?

कोरोना वैक्सीन अपडेट: रूस से भारत आएंगी 10 करोड़ वैक्सीन

कोविड-19 वैक्सीन स्पुतनिक-5 को लेकर रूस की एजेंसी आरडीआईएफ और डॉ रेड्डीज लेबोरेट्रेजी के बीच एक समझौता हुआ है

Simply Put: COVID-19 and Sri Ram’s arrow

COVID-19: Where India stands 6 months since Modi called for lockdown

As the country marks six months since the COVID-19 lockdown was imposed, its metropolitan cities have resumed public transport and offices, …

COVID-19: Trials for cure at a glance

Scientists across the globe are working to develop vaccines for the novel coronavirus disease while exploring whether existing drugs can be …

First 2 phases of Russian vaccine trial indicate safety and efficacy: Study

Two formulations of the vaccine have been developed: One could be introduced through global supply chain and other in hard-to-reach regions

Why COVID-19 will not kill off global business travel

In medium term, life sciences companies will continue to expand and view travel as a vital channel for maintaining new business in markets

No COVID-19 vaccine before 2021, Centre puts out then deletes

Sentence in question inadvertently included: PIB official; Things are contextual, says author of original article 

COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet

The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK

India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez

India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …

COVID-19: What will be a fair policy to distribute vaccine

No country is safe if only its own citizens are inoculated; the question of equitable distribution of a vaccine is as much a global concern as it …

India can exert itself as one of the largest vaccine manufacturers during COVID-19: Vaccinologist Peter Hotez

Hotez talked to DTE on India’s role in global vaccination, its challenges on the home turf, anti-vax movement and vaccine diplomacy